BioCentury | Jan 31, 2020
Product Development

CSL is harnessing its supply chain expertise to expand into cell and gene therapy

...core capabilities." CSL entered the cell and gene therapy space via its 2017 acquisition of Calimmune Inc....
...gained one gene therapy candidate and two stem cell technology platforms (see “CSL Behring Acquires Calimmune”...
...maximize what we do from our base business,” Perreault said. Setting the line up The Calimmune...
BioCentury | Jun 29, 2018
Product R&D

Highly personal

...lethality company Tango Therapeutics Inc., and Baltimore helped found immunotherapy companies Immune Design Corp. and Calimmune Inc....
BioCentury | Mar 19, 2018
Company News

Management tracks: J&J, Alder, CVS

...Pharmaceuticals Inc. (Cranbury, N.J.) hired Salim Yazji as CMO. He was EVP and CMO of Calimmune Inc....
BioCentury | Sep 1, 2017
Company News

CSL Behring acquires Calimmune

...The CSL Behring subsidiary of CSL Ltd. (ASX:CSL) said it will acquire gene therapy company Calimmune Inc....
...Ariz.), gaining two ex vivo autologous gene therapy candidates and two stem cell therapy technologies. Calimmune...
...company's personnel. CSL Ltd. (ASX:CSL), Melbourne, Australia Calimmune Inc. , Tucson, Ariz. Business: Hematology, Gene/Cell therapy Mary Romeo Cal-1 Calimmune Inc. CSL...
BioCentury | Aug 28, 2017
Company News

CSL Behring acquires Calimmune

...The CSL Behring subsidiary of CSL Ltd. (ASX:CSL) said it will acquire gene therapy company Calimmune Inc....
...Ariz.), gaining two ex vivo autologous gene therapy candidates and two stem cell therapy technologies. Calimmune...
...control of Calimmune following close of the transaction. de Vane said CSL Behring will maintain Calimmune's...
BioCentury | Dec 9, 2016
Company News

Cincinnati Children's Hospital, Calimmune deal

...hemoglobin subunit gamma (HBG) globin gene construct to treat sickle cell disease and beta thalassemia. Calimmune...
...which aims to improve engraftment of stem cell therapies through a post-cellular infusion selection process. Calimmune...
...Children's Hospital Medical Center , Cincinnati, Ohio Calimmune Inc. , Tucson, Ariz. Business: Hematology, Gene/Cell therapy Nora Weintraub Calimmune Inc. Cincinnati...
BioCentury | Jul 18, 2016
Company News

Management tracks

...as CEO and a director. The company is searching for a replacement. Gene therapy company Calimmune Inc....
BioCentury | Mar 31, 2016
Tools & Techniques

Postmodern ART

...inactivate CCR5 in patient cells ex vivo, and then transplant them back into the patient. Calimmune Inc....
...and Sangamo BioSciences Inc. both have autologous cell therapies in Phase I/II trials for HIV. Calimmune's...
...and others will likely allow dosing every three to four months Companies and Institutions Mentioned Calimmune Inc....
BioCentury | Mar 24, 2016
Company News

Management tracks

...SVP of research. King was CSO at AnaptysBio Inc. (San Diego, Calif.). Gene therapy company Calimmune...
BioCentury | Feb 1, 2016
Company News

Asklepios, Calimmune deal

...Asklepios granted Calimmune rights to Asklepios’ adeno-associated virus (AAV) gene therapy technologies, which Calimmune plans to...
...osteoarthritis. Asklepios will receive an upfront payment and is eligible to receive milestones and royalties. Calimmune...
...details, and Asklepios did not respond to inquiries. Asklepios BioPharmaceutical Inc. , Chapel Hill, N.C. Calimmune Inc....
Items per page:
1 - 10 of 18
BioCentury | Jan 31, 2020
Product Development

CSL is harnessing its supply chain expertise to expand into cell and gene therapy

...core capabilities." CSL entered the cell and gene therapy space via its 2017 acquisition of Calimmune Inc....
...gained one gene therapy candidate and two stem cell technology platforms (see “CSL Behring Acquires Calimmune”...
...maximize what we do from our base business,” Perreault said. Setting the line up The Calimmune...
BioCentury | Jun 29, 2018
Product R&D

Highly personal

...lethality company Tango Therapeutics Inc., and Baltimore helped found immunotherapy companies Immune Design Corp. and Calimmune Inc....
BioCentury | Mar 19, 2018
Company News

Management tracks: J&J, Alder, CVS

...Pharmaceuticals Inc. (Cranbury, N.J.) hired Salim Yazji as CMO. He was EVP and CMO of Calimmune Inc....
BioCentury | Sep 1, 2017
Company News

CSL Behring acquires Calimmune

...The CSL Behring subsidiary of CSL Ltd. (ASX:CSL) said it will acquire gene therapy company Calimmune Inc....
...Ariz.), gaining two ex vivo autologous gene therapy candidates and two stem cell therapy technologies. Calimmune...
...company's personnel. CSL Ltd. (ASX:CSL), Melbourne, Australia Calimmune Inc. , Tucson, Ariz. Business: Hematology, Gene/Cell therapy Mary Romeo Cal-1 Calimmune Inc. CSL...
BioCentury | Aug 28, 2017
Company News

CSL Behring acquires Calimmune

...The CSL Behring subsidiary of CSL Ltd. (ASX:CSL) said it will acquire gene therapy company Calimmune Inc....
...Ariz.), gaining two ex vivo autologous gene therapy candidates and two stem cell therapy technologies. Calimmune...
...control of Calimmune following close of the transaction. de Vane said CSL Behring will maintain Calimmune's...
BioCentury | Dec 9, 2016
Company News

Cincinnati Children's Hospital, Calimmune deal

...hemoglobin subunit gamma (HBG) globin gene construct to treat sickle cell disease and beta thalassemia. Calimmune...
...which aims to improve engraftment of stem cell therapies through a post-cellular infusion selection process. Calimmune...
...Children's Hospital Medical Center , Cincinnati, Ohio Calimmune Inc. , Tucson, Ariz. Business: Hematology, Gene/Cell therapy Nora Weintraub Calimmune Inc. Cincinnati...
BioCentury | Jul 18, 2016
Company News

Management tracks

...as CEO and a director. The company is searching for a replacement. Gene therapy company Calimmune Inc....
BioCentury | Mar 31, 2016
Tools & Techniques

Postmodern ART

...inactivate CCR5 in patient cells ex vivo, and then transplant them back into the patient. Calimmune Inc....
...and Sangamo BioSciences Inc. both have autologous cell therapies in Phase I/II trials for HIV. Calimmune's...
...and others will likely allow dosing every three to four months Companies and Institutions Mentioned Calimmune Inc....
BioCentury | Mar 24, 2016
Company News

Management tracks

...SVP of research. King was CSO at AnaptysBio Inc. (San Diego, Calif.). Gene therapy company Calimmune...
BioCentury | Feb 1, 2016
Company News

Asklepios, Calimmune deal

...Asklepios granted Calimmune rights to Asklepios’ adeno-associated virus (AAV) gene therapy technologies, which Calimmune plans to...
...osteoarthritis. Asklepios will receive an upfront payment and is eligible to receive milestones and royalties. Calimmune...
...details, and Asklepios did not respond to inquiries. Asklepios BioPharmaceutical Inc. , Chapel Hill, N.C. Calimmune Inc....
Items per page:
1 - 10 of 18